{{htmlmetatags>
metatag-keywords=(Fragilité)
metatag-og:title=(Effects of Ninjin'yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial. Ohbayashi H, et al, Int J Chron Obstruct Pulmon Dis 2024.)
metatag-description=(Traduction du résumé de l'article : Effects of Ninjin'yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial. Ohbayashi H, et al, International journal of chronic obstructive pulmonary disease 2024.)
metatag-og:type=article
metatag-article:published_time=2025-07-16
metatag-article:modified_time=2025-07-16
}}
{{page>:priv:keywords&nofooter&noeditbtn}}
~~NOTOC~~
{{pmid>addtt:38737191|Effects of Ninjin'yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial.}}
{{pmid>addhash_fr:38737191|Fragilité}}
====== Effects of Ninjin'yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial. Ohbayashi H, et al, Int J Chron Obstruct Pulmon Dis 2024. ======
{{tag>Fragilité }}
{{tag>Proposé_Via_Bot_Sans_HashTag}}
* **Proposé le :** 16/07/2025 07:07:08
* **Par :** [[:user:Bot]]
* **Avec la version du site :**
* **Revu par :**
* //Mettre votre nom d'utilisateur//
* //Mettre votre nom d'utilisateur//
{{tag>Proposé_à_relecture 2025-07 Non_attribué Non_finalisé}}
{{page>:veille:info:part_authors_instructions&noindent&nolink&nofooter&noeditbtn}}
===== Résumé et points clés =====
{{pmid>abstract_html:38737191}}
===== Références de l'article =====
{{pmid>listgroup:38737191}}
----
{{page>:veille:pm:discussion:38737191&nofooter&nolink&noindent}}
[[:veille:pm:discussion:38737191?do=edit|Éditer la discussion]]
----
===== Références =====
~~REFNOTES~~